Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 8/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 6/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31270778 | 0.86 | KDM4E (0.43) | GRIN2BADORA2B | |
| SCHEMBL25295149 | 0.86 | KDM4E (0.43) | GRIN2BADORA2B | |
| SCHEMBL31270671 | 0.86 | GRIN2B (0.60) | GRIN2BCYP3A4CYP2D6CYP2C9SMN1; SMN2 | |
| SCHEMBL25253285 | 0.86 | GRIN2B (0.60) | GRIN2BCYP3A4CYP2D6CYP2C9SMN1; SMN2 | |
| SCHEMBL15655668 | 0.85 | HCAR3 (0.35) | — | |
| SCHEMBL15655670 | 0.85 | HCAR3 (0.35) | — | |
| SCHEMBL29030594 | 0.84 | GRIN2B (0.44) | GRIN2BADORA2BCYP3A4CYP2D6CYP2C9 | |
| SCHEMBL25262335 | 0.83 | KCNH2 (0.37) | HTTPRKCQADORA2BCYP3A4CYP2D6 | |
| SCHEMBL31025949 | 0.83 | KCNH2 (0.37) | HTTPRKCQADORA2BCYP3A4CYP2D6 | |
| SCHEMBL15655776 | 0.79 | ADORA2B (0.33) | ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201933-A | Tri-fused ring compounds, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-116410317-A | Antibody-drug conjugate, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2023-07-11 | — | — | CN | disclosed |